Huvepharma® acquires the Animal Health Division of Neovia from InVivo Group
Huvepharma® acquires AgriLabs®, a leader in biological innovations for animal health in USA, delivering the next generation of animal health solutions for farm animals
Huvepharma® opens its first affiliate on the African continent – Huvepharma South Africa (Pty) Ltd
Huvepharma set up a representative office in Japan by the acquisition of the Japanese company NAI, developing and distributing Bio-D, a feed additive for poultry and swine
Huvepharma acquires CORID trademark from Merial Inc.
Huvepharma set up a representative office in Mexico
Acquisition of certain product range of Zoetis and related manufacturing facilities.
Acquisition of Garessio plant for chemical synthesis from Sanofi S.A
Acquisition of ANC (Animal Nutrition Center) Turkey.
Acquisition: Viridus (Novus) Animal Health LLC – ADVENT® vaccine
Acquisition: OptiPhos® portfolio Enzyvia LLC
Huvepharma through its subsidiary Biovet opens a new plant for production of biotechnological and pharmaceutical products in the town of Razgrad, Bulgaria.
Subsidiary company in Brazil
Huvepharma opens a subsidiary company in India
Huvepharma acquires certain anticoccidials and a formulation plant of Merial Inc. Representative office in Russia. Subsidiary company in Thailand.
Huvepharma receives a FDA approval and EU GMP certificate. Subsidiary company established in Taiwan. Representative office in China.
Huvepharma and Biovet receive feed additives GMP and HACCP certification by SGS (Ovocom). Acquisitions of Balkanpharma Razgrad, part of Actavis. Acquisition of Intervet's feed additives global business. Huvepharma sets up subsidiary companies in Belgium and the USA. Company's name is officially changed from Biovet to a global brand, Huvepharma (Human and Veterinary pharma).
Integrated quality and environmental management system ISO 9001/ISO 14001 implemented
Significant capital investments are made in the following areas: Plant upgrades, plant automation, construction of new production areas and warehouses, construction of granulating facilities and upgrades of quality control laboratories.
Huvepharma acquires Zelin (Botevgrad), an enzymes manufacturing plant.
Huvepharma acquires majority stake in Biovet (Peshtera)
Tylosin production line in the Razgrad plant is approved by FDA. GMP systems implemented and certified by authorities.
Tylosin production line at Razgrad plant is approved by FDA. Injectables and tableting are completed in Peshtera plant. ISO 9001-Biovet certified. GMP compliance certified.
Downstream processing facilities and wastewater treatment plants built in Peshtera and Razgrad
Production companies with R&D established in Peshtera, Razgrad and Botevgrad, Bulgaria.